NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells. 2016

Joanna Ratajczak, and Magali Joffraud, and Samuel A J Trammell, and Rosa Ras, and Núria Canela, and Marie Boutant, and Sameer S Kulkarni, and Marcelo Rodrigues, and Philip Redpath, and Marie E Migaud, and Johan Auwerx, and Oscar Yanes, and Charles Brenner, and Carles Cantó
Nestlé Institute of Health Sciences (NIHS), Lausanne CH-1015, Switzerland.

NAD+ is a vital redox cofactor and a substrate required for activity of various enzyme families, including sirtuins and poly(ADP-ribose) polymerases. Supplementation with NAD+ precursors, such as nicotinamide mononucleotide (NMN) or nicotinamide riboside (NR), protects against metabolic disease, neurodegenerative disorders and age-related physiological decline in mammals. Here we show that nicotinamide riboside kinase 1 (NRK1) is necessary and rate-limiting for the use of exogenous NR and NMN for NAD+ synthesis. Using genetic gain- and loss-of-function models, we further demonstrate that the role of NRK1 in driving NAD+ synthesis from other NAD+ precursors, such as nicotinamide or nicotinic acid, is dispensable. Using stable isotope-labelled compounds, we confirm NMN is metabolized extracellularly to NR that is then taken up by the cell and converted into NAD+. Our results indicate that mammalian cells require conversion of extracellular NMN to NR for cellular uptake and NAD+ synthesis, explaining the overlapping metabolic effects observed with the two compounds.

UI MeSH Term Description Entries
D007274 Injections, Intraperitoneal Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall. Intraperitoneal Injections,Injection, Intraperitoneal,Intraperitoneal Injection
D008322 Mammals Warm-blooded vertebrate animals belonging to the class Mammalia, including all that possess hair and suckle their young. Mammalia,Mammal
D009243 NAD A coenzyme composed of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by pyrophosphate linkage. It is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized (NAD+) and reduced (NADH). (Dorland, 27th ed) Coenzyme I,DPN,Diphosphopyridine Nucleotide,Nadide,Nicotinamide-Adenine Dinucleotide,Dihydronicotinamide Adenine Dinucleotide,NADH,Adenine Dinucleotide, Dihydronicotinamide,Dinucleotide, Dihydronicotinamide Adenine,Dinucleotide, Nicotinamide-Adenine,Nicotinamide Adenine Dinucleotide,Nucleotide, Diphosphopyridine
D009536 Niacinamide An important compound functioning as a component of the coenzyme NAD. Its primary significance is in the prevention and/or cure of blacktongue and PELLAGRA. Most animals cannot manufacture this compound in amounts sufficient to prevent nutritional deficiency and it therefore must be supplemented through dietary intake. Nicotinamide,Vitamin B 3,Vitamin PP,3-Pyridinecarboxamide,Enduramide,Nicobion,Nicotinsäureamid Jenapharm,Papulex,Vitamin B3,3 Pyridinecarboxamide,B 3, Vitamin,B3, Vitamin,Jenapharm, Nicotinsäureamid
D009537 Nicotinamide Mononucleotide 3-Carbamoyl-1-beta-D-ribofuranosyl pyridinium hydroxide-5'phosphate, inner salt. A nucleotide in which the nitrogenous base, nicotinamide, is in beta-N-glycosidic linkage with the C-1 position of D-ribose. Synonyms: Nicotinamide Ribonucleotide; NMN. Mononucleotide, Nicotinamide
D011726 Pyridinium Compounds Derivatives of PYRIDINE containing a cation C5H5NH or radical C5H6N. Compounds, Pyridinium
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D056945 Hep G2 Cells A human liver tumor cell line used to study a variety of liver-specific metabolic functions. Cell Line, Hep G2,Cell Line, Hepatoblastoma G2,Hep G2 Cell Line,HepG2 Cells,Hepatoblastoma G2 Cell Line,Cell, Hep G2,Cell, HepG2,Cells, Hep G2,Cells, HepG2,Hep G2 Cell,HepG2 Cell
D017853 Phosphotransferases (Alcohol Group Acceptor) A group of enzymes that transfers a phosphate group onto an alcohol group acceptor. EC 2.7.1.

Related Publications

Joanna Ratajczak, and Magali Joffraud, and Samuel A J Trammell, and Rosa Ras, and Núria Canela, and Marie Boutant, and Sameer S Kulkarni, and Marcelo Rodrigues, and Philip Redpath, and Marie E Migaud, and Johan Auwerx, and Oscar Yanes, and Charles Brenner, and Carles Cantó
December 2022, The Journal of biological chemistry,
Joanna Ratajczak, and Magali Joffraud, and Samuel A J Trammell, and Rosa Ras, and Núria Canela, and Marie Boutant, and Sameer S Kulkarni, and Marcelo Rodrigues, and Philip Redpath, and Marie E Migaud, and Johan Auwerx, and Oscar Yanes, and Charles Brenner, and Carles Cantó
August 2017, Molecular metabolism,
Joanna Ratajczak, and Magali Joffraud, and Samuel A J Trammell, and Rosa Ras, and Núria Canela, and Marie Boutant, and Sameer S Kulkarni, and Marcelo Rodrigues, and Philip Redpath, and Marie E Migaud, and Johan Auwerx, and Oscar Yanes, and Charles Brenner, and Carles Cantó
October 1977, Proceedings of the National Academy of Sciences of the United States of America,
Joanna Ratajczak, and Magali Joffraud, and Samuel A J Trammell, and Rosa Ras, and Núria Canela, and Marie Boutant, and Sameer S Kulkarni, and Marcelo Rodrigues, and Philip Redpath, and Marie E Migaud, and Johan Auwerx, and Oscar Yanes, and Charles Brenner, and Carles Cantó
August 2020, Biochemical pharmacology,
Joanna Ratajczak, and Magali Joffraud, and Samuel A J Trammell, and Rosa Ras, and Núria Canela, and Marie Boutant, and Sameer S Kulkarni, and Marcelo Rodrigues, and Philip Redpath, and Marie E Migaud, and Johan Auwerx, and Oscar Yanes, and Charles Brenner, and Carles Cantó
September 2023, Current nutrition reports,
Joanna Ratajczak, and Magali Joffraud, and Samuel A J Trammell, and Rosa Ras, and Núria Canela, and Marie Boutant, and Sameer S Kulkarni, and Marcelo Rodrigues, and Philip Redpath, and Marie E Migaud, and Johan Auwerx, and Oscar Yanes, and Charles Brenner, and Carles Cantó
March 2024, Biochemistry and biophysics reports,
Joanna Ratajczak, and Magali Joffraud, and Samuel A J Trammell, and Rosa Ras, and Núria Canela, and Marie Boutant, and Sameer S Kulkarni, and Marcelo Rodrigues, and Philip Redpath, and Marie E Migaud, and Johan Auwerx, and Oscar Yanes, and Charles Brenner, and Carles Cantó
December 2009, The Journal of biological chemistry,
Joanna Ratajczak, and Magali Joffraud, and Samuel A J Trammell, and Rosa Ras, and Núria Canela, and Marie Boutant, and Sameer S Kulkarni, and Marcelo Rodrigues, and Philip Redpath, and Marie E Migaud, and Johan Auwerx, and Oscar Yanes, and Charles Brenner, and Carles Cantó
May 2024, Pharmaceutical research,
Joanna Ratajczak, and Magali Joffraud, and Samuel A J Trammell, and Rosa Ras, and Núria Canela, and Marie Boutant, and Sameer S Kulkarni, and Marcelo Rodrigues, and Philip Redpath, and Marie E Migaud, and Johan Auwerx, and Oscar Yanes, and Charles Brenner, and Carles Cantó
April 2017, Food chemistry,
Joanna Ratajczak, and Magali Joffraud, and Samuel A J Trammell, and Rosa Ras, and Núria Canela, and Marie Boutant, and Sameer S Kulkarni, and Marcelo Rodrigues, and Philip Redpath, and Marie E Migaud, and Johan Auwerx, and Oscar Yanes, and Charles Brenner, and Carles Cantó
October 2022, Journal of drugs in dermatology : JDD,
Copied contents to your clipboard!